The PASTEUR Act establishes a subscription-style model for the U.S. government to secure a reliable supply of novel antimicrobials to address the most serious and life-threatening infections and combat the threat of antimicrobial resistance (AMR). By delinking payment from sales volume, PASTEUR ensures that payment reflects the value of antimicrobials to public health and supports their judicious use.